These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29206660)

  • 21. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
    Lo MS; Tsokos GC
    Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
    Robinson GA; Wilkinson MGL; Wincup C
    Front Immunol; 2021; 12():806560. PubMed ID: 35154082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
    Kammer GM
    J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus.
    Stypińska B; Paradowska-Gorycka A
    Int J Mol Sci; 2015 Oct; 16(10):24194-218. PubMed ID: 26473848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.
    Liossis SN; Melissaropoulos K
    Expert Opin Pharmacother; 2014 Apr; 15(6):833-40. PubMed ID: 24588739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The metabolic regulation in immune cells and pathogenesis of systemic lupus erythematosus ∼toward new therapeutic applications∼].
    Takeshima Y; Iwasaki Y; Okamura T; Fujio K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):12-20. PubMed ID: 28539549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytokine production in patients with systemic lupus erythematosus].
    Müzes G; González-Cabello R; Van Vien C; Fehér J; Gergely P
    Orv Hetil; 1991 Sep; 132(36):1971-4. PubMed ID: 1923468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
    Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
    J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus.
    Lo MS
    Front Immunol; 2018; 9():1278. PubMed ID: 29922296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
    Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
    Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 and systemic lupus erythematosus--fifteen years later.
    Crispin JC; Alcocer-Varela J
    Lupus; 1998; 7(4):214-22. PubMed ID: 9643310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.
    Taher TE; Parikh K; Flores-Borja F; Mletzko S; Isenberg DA; Peppelenbosch MP; Mageed RA
    Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?
    Hu SJ; Wen LL; Hu X; Yin XY; Cui Y; Yang S; Zhang XJ
    Mod Rheumatol; 2013 Mar; 23(2):205-9. PubMed ID: 22782532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA Damage and Deficiencies in the Mechanisms of Its Repair: Implications in the Pathogenesis of Systemic Lupus Erythematosus.
    Mireles-Canales MP; González-Chávez SA; Quiñonez-Flores CM; León-López EA; Pacheco-Tena C
    J Immunol Res; 2018; 2018():8214379. PubMed ID: 30116756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytokines in systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Robak T
    Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
    Nakayamada S; Saito K; Nakano K; Tanaka Y
    Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.